Case Report: Serum methotrexate monitoring by immunoassay: confusion by by-product, confusion by antidote
Methotrexate is a commonly used agent in the treatment of many malignancies and rheumatologic/inflammatory diseases. Working by inhibiting dihydrofolate reductase and thereby preventing eventual formation of tetrahydrofolate, methotrexate inhibits synthesis of purines and thymidylate, therefore disa...
Main Authors: | Aditya Sharma, Philip Benoit, Frederick Lansigan, David Nierenberg |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-10-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2023.1237178/full |
Similar Items
-
Routine use of low-dose glucarpidase following high-dose methotrexate in adult patients with CNS lymphoma: an open-label, multi-center phase I study
by: Lauren R. Schaff, et al.
Published: (2022-01-01) -
Development of a population pharmacokinetics and pharmacodynamics model of glucarpidase rescue treatment after high-dose methotrexate therapy
by: Yutaka Fukaya, et al.
Published: (2023-01-01) -
Methotrexate-induced acute cardiotoxicity requiring veno-arterial extracorporeal membrane oxygenation support: a case report
by: Sareena Shah, et al.
Published: (2022-11-01) -
Comparison of two doses of leucovorin in severe low-dose methotrexate toxicity – a randomized controlled trial
by: Mudit Bhargava, et al.
Published: (2023-05-01) -
A case of skin damage due to overdose methotrexate poisoning
by: Zhe ZHUANG, et al.
Published: (2022-08-01)